| For: | Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695 [PMID: 31528094 DOI: 10.3748/wjg.v25.i32.4682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i32/4682.htm |
| Number | Citing Articles |
| 1 |
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich, Mohsen Beheshti. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.916693
|
| 2 |
Sree Harshitha Vallabhaneni, Sri Sravya Lalitha Chandrika Thungathurthi, Prem Kurra, Supraj Teeparthy. Biliary Tract - Disease, Treatment, and Quality of Life. 2025; doi: 10.5772/intechopen.1010235
|
| 3 |
Matej Murgaš, Paul Michenthaler, Murray Bruce Reed, Gregor Gryglewski, Rupert Lanzenberger. Correlation of receptor density and mRNA expression patterns in the human cerebral cortex. NeuroImage 2022; 256 doi: 10.1016/j.neuroimage.2022.119214
|
| 4 |
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. Metabolites 2021; 11(1) doi: 10.3390/metabo11010054
|
| 5 |
Recep Erçin SÖNMEZ, Florent L. BESSON, Jerome GHİDAGLIA, Maïté LEWIN, Lea GOMEZ, Chady SALLOUM, Gabriella PITTAU, Oriana CIACIO, Marc Antoine ALLARD, Daniel CHERQUI, René ADAM, Antonio SA CUNHA, Daniel AZOULAY, Eric VİBERT, Nicolas GOLSE. Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2023; 67(3) doi: 10.23736/S1824-4785.22.03485-9
|
| 6 |
Dhuha Al-Adhami, Marwa Al-shatti, Kamal Alrabi, Mohammad Haidar, Akram Al-Ibraheem . High-Grade Hepatic Spindle Cell Carcinoma as a Cause of Diffuse Right Hepatic Lobe Hypermetabolism Identified With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging. Cureus 2024; doi: 10.7759/cureus.68793
|
| 7 |
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review. Diagnostics 2023; 13(4) doi: 10.3390/diagnostics13040625
|
| 8 |
Mohammad Mansoob Khan. Photocatalysts: Synthesis and Characterization Methods. 2025; doi: 10.1016/B978-0-443-28913-2.00019-8
|
| 9 |
Kazuhiro Katayama. Treatment strategy for and malignant potential of hepatocellular carcinoma within the Milan criteria. Kanzo 2021; 62(8) doi: 10.2957/kanzo.62.439
|
| 10 |
Abu Bakar Hafeez Bhatti, Wajih Naqvi, Nusrat Yar Khan, Haseeb Haider Zia, Faisal Saud Dar, Zahid Amin Khan, Atif Rana. Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion. Journal of Cancer Research and Clinical Oncology 2022; 148(1) doi: 10.1007/s00432-021-03665-9
|
| 11 |
Zhaoguo Lin, Mengting Li, Zhidi Pan, Wenzhu Hu, Yuan Feng, Xiao Zhang, Haiyang Yin, Shusheng Wang, Zhangyi Song, Xiaoying Lv, Xiangming Song, Danzha Zheng, Weiwei Ruan, Yongkang Gai, Ming Yang, Dawei Jiang, Xiong Cai, Jianwei Zhu, Xiaoli Lan. Glypican-3–Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside. Clinical Cancer Research 2026; 32(3) doi: 10.1158/1078-0432.CCR-25-1856
|
| 12 |
Marzieh Nejabat, Lucian Beer, Theresa Servus, Ahmed Ba-Ssalamah, Peter Mazal, Lukas Nics, Marcus Hacker, Georgios Karanikas, Sazan Rasul. Prognostic Value of 18F-FDG and 18F-FEC Uptake in Hepatocellular Carcinoma Using Contrast-Enhanced Integrated PET/MRI: Correlation with Histology and Survival. Cancers 2026; 18(10) doi: 10.3390/cancers18101526
|
| 13 |
Keith Wan Hang Chiu, Kel Vin Tan, Xinxiang Yang, Xiaoqiang Zhu, Jingjing Shi, Chi-Leung Chiang, Lawrence Chan, Yuan Hui, Pek-Lan Khong, Kwan Man, Jason Wing Hon Wong. Prognostic PET [11C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma – a bench to bed study. Cancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00685-9
|
| 14 |
Shaobo Wang, Boqiao Li, Pengfei Li, Ran Xie, Quanshi Wang, Hong Shi, Jianfeng He. Feasibility of perfusion and early-uptake 18F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake model. Japanese Journal of Radiology 2021; 39(11) doi: 10.1007/s11604-021-01140-6
|
| 15 |
Yan Hu, Guobing Liu, Haojun Yu, Jianying Gu, Hongcheng Shi. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(10) doi: 10.1007/s00259-022-05772-2
|
| 16 |
Erdal Çetinkaya, Fatih Güzel, Şadiye Altun Tuzcu, Bekir Taşdemir, İlbey Erkin Çetin, Kendal Yalçın. Hepatosellüler Karsinom Tanısında F-18 FDG PET/BT ile Ga-68 PSMA PET/BT Çalışmaların Rolü. Dicle Tıp Dergisi 2025; 52(4) doi: 10.5798/dicletip.1841151
|
| 17 |
Shubhangi Agarwal, Jeremy Gordon, Robert A. Bok, Cornelius von Morze, Daniel B. Vigneron, John Kurhanewicz, Michael A. Ohliger. Distinguishing metabolic signals of liver tumors from surrounding liver cells using hyperpolarized 13C MRI and gadoxetate. Magnetic Resonance in Medicine 2024; 91(5) doi: 10.1002/mrm.29918
|
| 18 |
Jordan D. LeGout, Ryan E. Bailey, Candice W. Bolan, Andrew W. Bowman, Frank Chen, Joseph G. Cernigliaro, Lauren F. Alexander. Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion. RadioGraphics 2020; 40(7) doi: 10.1148/rg.2020200047
|
| 19 |
Zhamilya Zholdybay, Zhanar Zhakenova, Bekzhan Issamatov, Madina Gabdullina, Yevgeniya Filippenko, Suriya Yessentayeva, Galymzhan Alisherov, Jandos Amankulov, Ildar Fakhradiyev. 68Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels. Diagnostics 2026; 16(2) doi: 10.3390/diagnostics16020249
|
| 20 |
Yuzhen Jin, Yi Yang, Qingling Li, Tingting Long, Shuo Hu. 18F-FDG PET/CT Finding of Hepatocellular Carcinoma Mimicking Focal Fat Sparing in Severe Fatty Liver. Clinical Nuclear Medicine 2026; 51(6) doi: 10.1097/RLU.0000000000006374
|
| 21 |
Calvin Sidhu, Lokesh Yagnik. Recurrent hepatocellular carcinoma presenting as thoracic lymphadenopathy. Respirology Case Reports 2021; 9(7) doi: 10.1002/rcr2.792
|
| 22 |
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liver. Clinical Hemorheology and Microcirculation 2022; 80(4) doi: 10.3233/CH-211309
|
| 23 |
Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke, Freddy E. Escorcia. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET. Journal of Nuclear Medicine 2023; 64(7) doi: 10.2967/jnumed.122.265171
|
| 24 |
N. E. Nyakale, C. Aldous, A. A. Gutta, X. Khuzwayo, L. Harry, M. M. Sathekge. Emerging theragnostic radionuclide applications for hepatocellular carcinoma. Frontiers in Nuclear Medicine 2023; 3 doi: 10.3389/fnume.2023.1210982
|
| 25 |
Tao Wang, Boqiao Li, Hong Shi, Pengfei Li, Yinglei Deng, Siyu Wang, Qiao Luo, Dongdong Xv, Jianfeng He, Shaobo Wang. Short-term PET-derived kinetic estimation for the diagnosis of hepatocellular carcinoma: a combination of the maximum-slope method and dual-input three-compartment model. Insights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01442-5
|
| 26 |
Zihan Meng, Boyu Tan, Min Wang, Jiamin Zhu, Chunrong Qu, Zhen Cheng. Development of a Cyclic TMTP1-Based PET Probe for Visualization of Hepatocellular Carcinoma. ACS Medicinal Chemistry Letters 2025; 16(4) doi: 10.1021/acsmedchemlett.5c00008
|
| 27 |
Ryan Bitar, Riad Salem, Richard Finn, Tim F. Greten, S. Nahum Goldberg, Julius Chapiro. Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma. Radiology 2024; 313(2) doi: 10.1148/radiol.232875
|
| 28 |
Lixing Chen, Siyuan Cheng, Dongling Zhu, Guangfa Bao, Ziqiang Wang, Xiaoyun Deng, Xiaoguang Liu, Xiang Ma, Jun Zhao, Lei Zhu, Xiaohua Zhu. Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging. Molecular Pharmaceutics 2025; 22(1) doi: 10.1021/acs.molpharmaceut.4c00838
|
| 29 |
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelines. Gastrointestinal Nursing 2020; 18(Sup10) doi: 10.12968/gasn.2020.18.Sup10.S18
|
| 30 |
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024; doi: 10.7759/cureus.72239
|
| 31 |
Kiran Arshad, Sheikh Danial Hanan, Muhammad Numair Younis, Rimsha Badar, Minahil Imran, Nefal Numair, Abubakar Imran. Detection of Primary Hepatocellular Carcinoma on18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography. Euroasian journal of hepato-gastroenterology 2023; 13(2) doi: 10.5005/jp-journals-10018-1409
|
| 32 |
Ender Anılır, Alihan Oral, Fatih Turker, Tolga Şahin, Feyza Sönmez Topçu, Yıldıray Yuzer, Yaman Tokat. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer. Transplantation Proceedings 2024; 56(1) doi: 10.1016/j.transproceed.2023.12.007
|
| 33 |
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 2022; doi: 10.2147/IJN.S349426
|
| 34 |
Ke-Xin Sun, Zhen-Peng Yu, Jia-Lun Luo, Zhi-Qiang Yu, Hong Zhu, Tao Wu, Peng-Fei Dai, Hongwei Si. Synthesis and biological evaluation of 68Ga-DOTA-AngII as a radiotracer for PET/MR imaging of hepatocellular carcinoma. Bioorganic & Medicinal Chemistry 2025; 125 doi: 10.1016/j.bmc.2025.118221
|
| 35 |
David Brasse, Hélène Burckel, Patrice Marchand, Marc Rousseau, Ali Ouadi, Marie Vanstalle, Christian Finck, Patrice Laquerriere, Frédéric Boisson. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma. Molecular Imaging and Biology 2021; 23(5) doi: 10.1007/s11307-021-01602-3
|
| 36 |
Mai M. K. Barakat, Ethar M. Badran, Yasmine Emad Aldin Hassan Allam, Zenat Ahmed Alsabbagh, Ahmed S. Abdelrahman. The role of triphasic CT imaging and 18F FDG PET CT on detection of extrahepatic metastases and proper staging of HCC: a comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2022; 53(1) doi: 10.1186/s43055-022-00808-x
|
| 37 |
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
|
| 38 |
Bingqian Zhang, Mingyue Zou, Zengxin Lu, Haijia Mao, Ya’nan Huang, Fang Liu, Zhenhua Zhao. Imaging Manifestations of Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Literature Review. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.694934
|
| 39 |
Alejandro Serrablo, Alejandra Utrillas-Fornals, Pablo Parra, Luis Tejedor, Leyre Serrablo. Regenerative Hepatology and Liver Transplantation. 2025; doi: 10.1016/B978-0-12-823524-9.00011-3
|
| 40 |
Jianfeng He, Tao Wang, Yongjin Li, Yinglei Deng, Shaobo Wang. Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on 18F-FDG PET/CT. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00742-4
|
| 41 |
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utility. Clinical and Translational Imaging 2020; 8(5) doi: 10.1007/s40336-020-00384-y
|
| 42 |
Kanhaiyalal Agrawal, Sayak Choudhury, Arvind Suresh, Archi Agrawal, Gopinath Gnanasegaran. Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology. 2021; doi: 10.1007/978-3-030-68858-5_14
|
| 43 |
Jiucen Liang, Anqi Li, Shuyi Li, Shuqin Jiang, Wen Li, Zhidong Liu, Hao Peng, Sha Yan, Mengqi Zhou, Rusen Zhang, Qiao He, Linqi Zhang. Diagnostic value of [18F]FAPI-04 PET/CT in patients with monofocal liver lesions suspicious for hepatocellular carcinoma: a prospective comparison with LI-RADS-based contrast-enhanced CT/MRI. European Journal of Nuclear Medicine and Molecular Imaging 2026; 53(8) doi: 10.1007/s00259-026-07840-3
|
| 44 |
Lina Garcia Cañamaque, Felipe S. Furtado, Caroline Ann Field Galán, Grace Lo, Mercedes Mitjavilla Casanovas, Yolanda Quijano Collazo, Cristina Ferrone, Jeffrey W. Clark, Onofrio Antonio Catalano. Clinical PET/MRI. 2023; doi: 10.1016/B978-0-323-88537-9.00014-3
|
| 45 |
Matteo Renzulli, Nicolò Brandi, Giulia Argalia, Stefano Brocchi, Andrea Farolfi, Stefano Fanti, Rita Golfieri. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions. La radiologia medica 2022; 127(2) doi: 10.1007/s11547-022-01449-w
|
| 46 |
Xiaowei Fan, Xiaoxiao Wang, Zijing Li, Yesen Li. 68Ga-Labeled TMTP1 Derivatives with Moderate Hydrophilicity for Positron Emission Tomography of Hepatocellular Carcinoma in High Contrast. Journal of Medicinal Chemistry 2023; 66(10) doi: 10.1021/acs.jmedchem.3c00111
|
| 47 |
Akhil Pulumati, Anika Pulumati, Bilikere S. Dwarakanath, Amit Verma, Rao V. L. Papineni. Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Reports 2023; 6(2) doi: 10.1002/cnr2.1764
|
| 48 |
Mehmet Karagözlü, Süleyman Aşır, Deniz Türkmen, Ammar Zidan, Fatma Hacıoğulları, Adil Denizli. Functionalized Magnetic Nanoparticles for Theranostic Applications. 2024; doi: 10.1002/9781394172917.ch6
|
| 49 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1) doi: 10.1016/j.jceh.2023.08.005
|
| 50 |
Madunil Anuk Niriella, Uditha Dassanayake, H Janaka de Silva. Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review. Expert Review of Gastroenterology & Hepatology 2023; 17(9) doi: 10.1080/17474124.2023.2255515
|
| 51 |
Vanessa Murad, E. Edmund Kim, Jin-Chul Paeng, Hyung-Jun Im, Gi-Jeong Cheon. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. 2022; doi: 10.1007/978-3-030-92349-5_1
|
| 52 |
Wenzhu Hu, Lixia Feng, Yan Wang, Zhaoguo Lin, Yuan Feng, Xingyi Wang, Yupin Tan, Dawei Jiang, Mengting Li, Weijun Wei, Xiaoli Lan. Development and Evaluation of an Albumin-Binding GPC3-Targeting Peptide for PET Imaging of Hepatocellular Carcinoma. Molecular Pharmaceutics 2026; doi: 10.1021/acs.molpharmaceut.6c00222
|
| 53 |
Hong Yang, Bingbing Yang, Yu Teng, Jun Ge, Xinchi Feng, Yulin Tian. Identification of α-tubulin alpha-1B chain as a target of asiatic acid using chemical proteomics in HepG2 hepatoma cells. Organic & Biomolecular Chemistry 2024; 22(48) doi: 10.1039/D4OB01298D
|
| 54 |
Takumi Yamamoto, Seikan Miyashita, Shinpei Eguchi, Takahiro Uenishi. A Case of Rapidly Enlarging HNF1α-inactivated Hepatocellular Adenoma with Elevated PIVKA-II Levels. Kanzo 2025; 66(4) doi: 10.2957/kanzo.66.140
|
| 55 |
Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng, Pierpaolo Alongi. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness. PLOS ONE 2021; 16(3) doi: 10.1371/journal.pone.0249003
|
| 56 |
Yanjie Wang, Yuan Sun, Xueyuan Zeng, Rongqiang Zhuang, Jinxiong Huang, Xianzhong Zhang, Zhide Guo, Yesen Li. 68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular Carcinoma. Journal of Medicinal Chemistry 2024; 67(3) doi: 10.1021/acs.jmedchem.3c02090
|
| 57 |
Vanessa Murad, E. Edmund Kim, Jin-Chul Paeng, Camilo Barragan, Gi-Jeong Cheon. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. 2022; doi: 10.1007/978-3-030-92349-5_2
|
| 58 |
Yannick Kuhl, Stephan Naunheim, David Schug, Volkmar Schulz, Florian Mueller. Angular Irradiation Methods for DOI Calibration of Light-Sharing Detectors—A Perspective for PET In-System Calibration. IEEE Transactions on Radiation and Plasma Medical Sciences 2023; 7(7) doi: 10.1109/TRPMS.2023.3272015
|
| 59 |
Anurima Patra, Hala Khasawneh, Garima Suman, Mark A. Nathan, Annie T. Packard, Geoffrey B. Johnson, Ajit H. Goenka. Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer:11C-Choline PET/CT With Multimodality Correlation. American Journal of Roentgenology 2022; 218(1) doi: 10.2214/AJR.21.26426
|
| 60 |
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics of North America 2021; 59(5) doi: 10.1016/j.rcl.2021.06.001
|
| 61 |
|
| 62 |
Ashif Ahamed, Mahmadul Hasan, Arijit Samanta, Syed Sahajada Mahafujul Alam, Zarnain Jamil, Safdar Ali, Mehboob Hoque. Prospective pharmacological potential of cryptotanshinone in cancer therapy. Pharmacological Research - Modern Chinese Medicine 2023; 9 doi: 10.1016/j.prmcm.2023.100308
|
| 63 |
Kenneth Harland, Deborah Liaw, Yoana Ivanova, Yosef Nafii, Charles Preuss. Emerging Trends in Cancer Research. 2026; doi: 10.1016/B978-0-443-43870-7.00001-1
|
| 64 |
Qian Xue, Jianping Wu, Zehua Lei, Qing Wang, Weifeng Gao, Jinqiang Fu. Application value of fluorescence visualization-assisted technology in the resection of liver cancer: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy 2022; 39 doi: 10.1016/j.pdpdt.2022.102940
|
| 65 |
Kuncai Xu, Zhiqiang Zhu, Yanmin Liu, Yan Chen, Maorong Li, Deke Wu. FCSD-Net: A fourier convolution and state-space duality network for multi-modal medical image fusion. Journal of King Saud University Computer and Information Sciences 2026; 38(5) doi: 10.1007/s44443-026-00574-0
|
| 66 |
Preethi Guniganti, Andrea S. Kierans. PET/MRI of the hepatobiliary system: Review of techniques and applications. Clinical Imaging 2021; 71 doi: 10.1016/j.clinimag.2020.10.056
|
| 67 |
Nicholas Hannah, Catherine Yu, Leya Nedumannil, James Haridy, Grace Kong, Alex Boussioutas, Siddharth Sood. Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis. Cancers 2024; 16(22) doi: 10.3390/cancers16223865
|
| 68 |
Sami Akbulut, Tevfik Tolga Sahin. Hepatocellular carcinoma arising from ectopic liver tissue: a systematic review of the literature. European Journal of Gastroenterology & Hepatology 2026; 38(3) doi: 10.1097/MEG.0000000000003069
|
| 69 |
Yi Luo, Lei Song, Xinyu Wang, Yujie Huang, Yongqiang Liu, Qi Wang, Ming Hong, Zhongyu Yuan. Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01264
|
| 70 |
Junya Mita, Takashi Maeda, Eiji Tsujita, Kyohei Yugawa, Shintaro Takaki, Keiji Tsuji, Naotaka Hashimoto, Ranma Fujikawa, Yuki Ono, Akihiro Sakai, Shinichi Tanaka, Rumi Matono, Takahiro Ohmine, Takuro Kometani, Shohei Yamaguchi, Kozo Konishi, Kenkichi Hashimoto. A case of difficult-to-diagnose hepatic reactive lymphoid hyperplasia finally diagnosed by using PCR analysis of IgH-gene rearrangements: a case report. International Cancer Conference Journal 2023; 13(1) doi: 10.1007/s13691-023-00632-8
|
| 71 |
Trinh Nguyen, Jaijo Vennatt, Lincoln Downs, Venkateswar Surabhi, Nir Stanietzky. Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques. Journal of Gastrointestinal Cancer 2024; 55(4) doi: 10.1007/s12029-024-01094-8
|
| 72 |
Abid Suddle, Helen Reeves, Richard Hubner, Aileen Marshall, Ian Rowe, Dina Tiniakos, Stefan Hubscher, Mark Callaway, Dinesh Sharma, Teik Choon See, Maria Hawkins, Suzanne Ford-Dunn, Sarah Selemani, Tim Meyer. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults. Gut 2024; 73(8) doi: 10.1136/gutjnl-2023-331695
|
| 73 |
Tao Wang, Yinglei Deng, Sidan Wang, Jianfeng He, Shaobo Wang. Kinetic 18F-FDG PET/CT imaging of hepatocellular carcinoma: a dual input four-compartment model. EJNMMI Physics 2024; 11(1) doi: 10.1186/s40658-024-00619-1
|
| 74 |
Yushuang Qin, Siyuan Cheng, Yesen Li, Sijuan Zou, Minglong Chen, Dongling Zhu, Shi Gao, Hua Wu, Lei Zhu, Xiaohua Zhu. The development of a Glypican-3-specific binding peptide usingin vivoandin vitrotwo-step phage display screening for the PET imaging of hepatocellular carcinoma. Biomaterials Science 2020; 8(20) doi: 10.1039/D0BM00943A
|
| 75 |
Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, Johannes H. van Snick, Mostafa Roya, Dik ten Hove, Adrienne H. Brouwers, Adriaan A. Lammertsma, Walter Noordzij, Rudi A.J.O. Dierckx, Riemer H.J.A. Slart, Andor W.J.M. Glaudemans. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT. Cancer Imaging 2022; 22(1) doi: 10.1186/s40644-022-00507-w
|
| 76 |
Yaoru Huang, Po-Yung Chen, Tzu-Yen Cheng, Jeng-Fong Chiou. Hepatic Reirradiation for Patients with Recurrent Hepatocellular Carcinoma. Applied Sciences 2021; 11(4) doi: 10.3390/app11041598
|
| 77 |
Zacharias Chalampalakis, Markus Ortner, Masar Almuttairi, Martin Bauer, Ernesto Gomez Tamm, Albrecht Ingo Schmidt, Barbara Katharina Geist, Marcus Hacker, Oliver Langer, Roberta Frass-Kriegl, Ivo Rausch. Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study. EJNMMI Physics 2024; 11(1) doi: 10.1186/s40658-024-00694-4
|
| 78 |
Nozipho Nyakale, Luca Filippi, Colleen Aldous, Mike Sathekge. Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma. Cancers 2023; 15(7) doi: 10.3390/cancers15071975
|
| 79 |
Dima Malkawi, Ioannis A. Ziogas, Ana L. Gleisner, Richard D. Schulick, Dimitrios P. Moris. Non-Transplantable Recurrence After Initial Liver Resection of Hepatocellular Carcinoma: A Narrative Review. Cancers 2026; 18(2) doi: 10.3390/cancers18020317
|